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Abstract
 .  .Glycosylphosphatidylinositol GPI -specific phospholipase D GPI-PLD is a secretory protein present in high amounts
in mammalian body fluids. Its cDNA has been isolated and encodes a signal peptide of 23 amino acids and the mature
protein of 816 amino acids. We generated cDNAs encoding a signal peptide-deficient and a GPI-anchored form of GPI-PLD
and transiently transfected these constructs into COS-1 cells. The signal peptide-deficient form of GPI-PLD was expressed
as a 90-kDa protein that was catalytically active and was localized intracellularly. Cells transfected with cDNA encoding the
GPI-anchored form of GPI-PLD expressed a catalytically active enzyme of 100 kDa that could be labelled with
w3 xH ethanolamine demonstrating its modification by a GPI structure. Expression of the GPI-anchored form of GPI-PLD
resulted in the release of endogenous GPI-anchored alkaline phosphatase from COS-1 cells, whereas expression of the
intracellular form of GPI-PLD had no effect on membrane attachment of endogenous alkaline phosphatase. Similarly, in
 .cells cotransfected with GPI-anchored placental alkaline phosphatase PLAP and the GPI-anchored form of GPI-PLD,
PLAP was released into the cell culture supernatant while expression of the signal peptide-deficient form of GPI-PLD did
not affect the amount of cell-associated PLAP. q 1997 Elsevier Science B.V.
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1. Introduction
Covalently attached glycosylphosphatidylinositols
 .aGPIs that are used as membrane anchors by a large
 w x.number of cell surface proteins for reviews see 1,2
can be hydrolyzed by two types of phospholipases.
GPI-hydrolyzing phospholipases C from bacteria
w x w x w x3,4 , trypanosomes 5–8 , and plants 9 have been
shown to cleave non-inositol acylated GPI structures
 .as well as phosphatidylinositol PI , and the bacterial
enzymes are now widely used to release GPI-anchored
proteins from cell surfaces. GPI-specific phospholi-
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 . w xpases D GPI-PLDs from mammalian sera 10–13
readily hydrolyze GPI structures including inositol
acylated GPIs in vitro but are inactive on PI. In
addition, membrane-attached GPI-anchored proteins
seem to be poor substrates for purified GPI-PLDs
w x14 . GPI-PLD activity has also been reported in the
w x w xislets of Langerhans 15 , in mast cells 16,17 , bovine
w x w xbrain 18 , and neurons 19 . The GPI-PLD primary
structure has been deduced from a full length cDNA
w xconstruct from bovine liver cDNA libraries 20 .
GPI-PLD has been isolated from bovine serum as
a glycoprotein with an apparent molecular mass of
w x115 kDa 21 . In addition, a 47 kDa immunoreactive
form of GPI-PLD that is catalytically active and has a
N-terminus identical to that of the intact enzyme has
w xbeen detected in GPI-PLD isolates from serum 22 .
w x w xHeller et al. 23 and Li et al. 24 have subsequently
shown that treatment of purified GPI-PLD with
trypsin resulted in the generation of three major
fragments of 30–42 kDa, and that a 39-kDa N-termi-
w xnal polypeptide was catalytically active 23 .
Due to the limited ability of GPI-PLD to hydrolyze
w xmembrane-bound GPI-anchored proteins 14 , it has
been difficult to propose a role for the enzyme in
w xvivo. Scallon et al. 20 have shown that in COS-1
cells cotransfected with GPI-PLD and GPI-anchored
 .placental alkaline phosphatase PLAP , most of PLAP
was secreted into the culture medium whereas in the
absence of GPI-PLD, PLAP was attached to the cell
w xmembrane. In addition, Bernasconi et al. 25 have
demonstrated that a GPI-anchored form of rubella
virus glycoprotein E1 was cleaved by GPI-PLD when
cotransfected on the same expression vector in COS-1
cells. These observations suggest that an intracellular
compartment may provide a better environment for
GPI hydrolysis by GPI-PLD than the cell surface.
However, in the above reports a possible action of
GPI-PLD on membrane-bound GPI-anchored pro-
teins was studied using transiently expressed proteins
only, and it is not known if the expression of GPI-PLD
in cells may also affect endogenous GPI-anchored
substrates.
In the present work, we studied the effects of
GPI-PLD expression in COS-1 cells on the mem-
brane attachment of endogenous GPI-anchored alka-
line phosphatase and cotransfected PLAP. For this
purpose we generated two novel forms of GPI-PLD,
i.e. a signal peptide-deficient and a GPI-anchored
form of the enzyme, and transiently expressed them
and the wild-type form of GPI-PLD in COS-1 cells.
2. Materials and methods
2.1. Materials
All reagents were of analytical grade and either
 .from Boehringer Mannheim, Germany , Fluka
 .  .Buchs, Switzerland , Sigma St. Louis, MO, USA ,
 .or Merck Darmstadt, Germany . Dulbecco’s modi-
 .fied Eagle’s medium DMEM with L-glutamine was
 .obtained from Seromed Basel, Switzerland , and
 .fetal calf serum FCS and penicillin were from
 .Seback Aidenbach, Germany . BACTO trypsin was
 .from DIFCO Laboratories Detroit, MI, USA . Acryl-
amide stock solution was from National Diagnostics
 .  .Hull, UK and polyvinylidene difluoride PVDF
 .membranes from Millipore Bedford, MA, USA .
Protein G-Sepharose beads were purchased from
 .Pharmacia Fine Chemicals Uppsala, Sweden . Un-
less otherwise stated, oligonucleotide primers were
 .from MWG-Biotech Munchenstein, Switzerland or¨
 .Microsynth Balgach, Switzerland . Phosphatidyli-
 .nositol-specific phospholipase C PI-PLC from
Bacillus cereus was from Boehringer Mannheim,
.Germany .
w3 xH Myristate-labelled variant surface glycoprotein
 .VSG from bloodstream form trypanosomes was
w xprepared essentially according to Hereld et al. 26 as
w xdescribed elsewhere 27 . The membrane-form of
 .acetylcholinesterase AChE was purified from bovine
w xerythrocytes as described by Brodbeck et al. 28 .
 .Mouse monoclonal antibody purified IgG against1
purified GPI-PLD from bovine serum was prepared
by Dr. J. Liao in the laboratory of Dr. B. Nørgaard-
 .Pedersen Copenhagen, Denmark . Horseradish-per-
oxidase-labelled anti-mouse IgG was from BioRad
 .Hercules, CA, USA , and fluorescein isothiocyanate
 .FITC -conjugated anti-mouse immunoglobulin from
 .Dako Glostrup, Denmark .
2.2. Cell cultures
COS-1 cells kindly provided by Dr. E. Sterchi,
.Bern, Switzerland were cultured at 378C in DMEM
 . supplemented with 10% vrv FCS, penicillin 200
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.  .  .unitsrml , glucose 1 grl , and NaHCO 2.0 grl .3
Transfected cells were grown in DMEM supple-
 .mented with 10% vrv GPI-PLD-inactivated FCS
 .see below . After incubation, culture supernatants
were collected, briefly centrifuged at 48C to remove
swimming cells and cell debris, and stored at 48C.
The adhering cells were washed with ice-cold 0.9%
 .wrv NaCl, scraped off the culture plates, and cen-
 .trifuged at low speed 250=g for 5 min at 48C.
After an additional washing and centrifugation step
the cell pellets were stored at y208C.
2.3. Inacti˝ation of GPI-PLD in FCS
In order to inactivate the GPI-hydrolyzing activity
present in serum, FCS was incubated at pH 11 for 1 h
at 378C. Subsequently, the pH was adjusted to pH 7.4
 .using concentrated 37% by vol. hydrochloric acid.
After this treatment GPI-hydrolyzing activity was no
longer detectable i.e. -0.1% of control untreated
.FCS . This treatment also inactivated alkaline phos-
phatase activity present in FCS i.e. -0.3% of con-
.trol untreated FCS .
2.4. Generation of cDNAs encoding a signal
peptide-deficient and a GPI-anchored form of GPI-
PLD
The plasmid pBJ1685 containing the complete
w x bovine liver GPI-PLD cDNA 20 Genbank se-
.quence m60804 was kindly provided by Dr. J.P.
 .Kochan Hoffmann-La Roche, Nutley, NJ, USA .
w x  .PLAP cDNA 29 Genbank sequence m12551 on
the mammalian expression vector pCMVb was ob-
 .tained from Dr. N. Fasel Lausanne, Switzerland .
Using the polymerase chain reaction with Vent eR
polymerase New England Biolabs, Beverly, MA,
.USA we constructed a signal peptide-deficient and a
 .GPI-anchored form of GPI-PLD Fig. 1 . The signal
peptide-deficient form of GPI-PLD form was gener-
ated by deleting the signal peptide sequence posi-
.tions 1–108 on the GPI-PLD cDNA and introducing
 .a start codon ATG in front of the sequence encod-
ing the mature protein. To generate a GPI-anchored
form of GPI-PLD, a 105 bp C-terminal fragment of
the PLAP cDNA encoding the cleavagerattachment
site and the hydrophobic domain necessary for GPI
anchor attachment positions 1514–1618 on PLAP
Fig. 1. GPI-PLD constructs used for expression in COS-1 cells.
 .A The constructs were generated as described in Section 2. All
constructs were cloned into the single EcoRI site of the eukary-
 .otic expression vector pSG5. hatched signal peptide sequence of
 .GPI-PLD cDNA; B mature peptide sequence of GPI-PLD
 .  .cDNA; I GPI anchor signal sequence of PLAP cDNA. B
The C-terminus of the wild-type GPI-PLD is shown with the
amino acid residues from position 801, followed by the 34 amino
acid residues of PLAP which lead to the GPI-anchoring.
.cDNA was amplified. This fragment containing a
NgoMI restriction site at the 5X-end was then ligated
to the C-terminus of bovine liver GPI-PLD cDNA
previously modified by insertion of a NgoMI restric-
tion site to obtain an in-frame fusion. Wild-type,
signal peptide-deficient, and GPI-anchored GPI-PLD
constructs were cloned into the single EcoRI site of
the eukaryotic expression vector pSG5 Stratagene,
.La Jolla, CA, USA resulting in the plasmids
pSG5rPLD-wt, pSG5rPLD-spd, and pSG5rPLD-
gpi, respectively.
2.5. Transient expression of GPI-PLD in COS-1 cells
 5Exponentially growing COS-1 cells 4–5P10
.cells were seeded onto 60 mm cell culture dishes 24
h before transfection. The DEAE-dextran-mediated
transfection method was performed essentially as de-
w xscribed by Cullen 30 . The transfection cocktail con-
taining 500 ng cDNA construct and 0.5 mgrml
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DEAE-dextran in 1 ml PBS was added to washed
COS-1 cells and incubated for 30 min at 378C. Tissue
 .culture medium 4 ml supplemented with 100
mmolrl chloroquine was added and the cells were
incubated again at 378C for 2.5 h. After a shock with
 .10% vrv dimethylsulfoxide in DMEM containing
 .10% vrv GPI-PLD-inactivated FCS for 2.5 min at
378C, the cells were grown for 48–72 h in 5 ml
 .DMEM containing 10% vrv GPI-PLD-inactivated
FCS.
For cotransfection experiments 500 ng of PLAP
cDNA and 500 ng of GPI-PLD cDNA construct were
co-introduced into COS-1 cells using the method
described above. The cells were grown for 72 h at
 .378C in 3 ml DMEM containing 10% vrv GPI-
PLD-inactivated FCS.
w 3 xLabelling of COS-1 cells with 1- H ethan-1-ol-2-
w 3 xamine hydrochloride H ethanolamine; 29
.Cirmmol; Amersham, Buckinghamshire, UK was
performed 24 h posttransfection by adding 100 mCi
w3 xH ethanolamine to the culture medium. After 24 h
the cells and cell culture supernatants were collected
as described above.
2.6. Assay for GPI-PLD acti˝ity
Cell pellets were sonicated in 200 ml 50 mmolrl
Mes, pH 6.5, for 10 s at 50 W. Aliquots of sonicated
cells and culture supernatants were assayed for GPI-
PLD activity in 50 mmolrl Mes, pH 6.5, 0.1 mmolrl
 .CaCl , Triton X-100 see below , containing 0.62
pmol purified GPI-anchored AChE from bovine ery-
throcytes as substrate, in a final volume of 25 ml
w x23 . The assay was started by putting the tubes at
378C in a water bath. The product of the reaction i.e.
.soluble AChE was separated from the substrate by
w xphase separation in Triton X-114 31 , and AChE
activity was measured according to Ellmann et al.
w x32 .
GPI-PLD activity is routinely measured in the
presence of detergent with maximal activity observed
at the critical micellar concentration of Triton X-100
w x18 . However, in the presence of lipids the activity
maximum of GPI-PLD is shifted towards higher de-
w xtergent concentrations 8 . We found that maximal
GPI-PLD activity in cell culture supernatants was at
 .0.018% wrv Triton X-100 whereas in cell lysates
 .the activity maximum was at 0.05% wrv Triton
X-100.
In some experiments GPI hydrolysis was deter-
w3 xmined using H myristate-labelled VSG as substrate
w xexactly as described by Butikofer and Brodbeck 9 .¨
2.7. Assay for alkaline phosphatase
 .Aliquots of sonicated cells 20 ml or culture
 .supernatants 50 ml were added to 150 ml assay
solution containing 1.33 M diethanolamine, pH 9.8,
0.66 mmolrl MgCl , and 13.33 mmolrl p-2
nitrophenylphosphate, and assayed in a final volume
 .of 200 ml. Cell lysates 10 ml and culture super-
 .natants 45 ml of COS-1 cells transfected with PLAP
were assayed in the presence of 10 mmolrl ho-
moarginine to inhibit the tissue-unspecific isoenzyme
w x33 . Conversion of p-nitrophenylphosphate to p-
nitrophenol was measured spectrophotometrically at
405 nm over a period of 5–15 min at room tempera-
ture.
2.8. PI-PLC treatment of endogenous alkaline phos-
phatase and transfected PLAP in COS-1 cells
GPI-anchoring of endogenous alkaline phosphatase
and transfected PLAP in COS-1 cells was studied as
 .follows. Sonicated lysates 20 ml of non-transfected
and PLAP-transfected cells were added to a cocktail
containing 20 mmolrl Tris-HCl, pH 7.4, 10 mmolrl
 .MgCl to maintain alkaline phosphatase activity ,2
 .0.5% wrv Triton X-100, and 0.03 U PI-PLC. The
 .reaction mixture 50 ml final volume was incubated
for 3–4 h at 378C and the enzymatic reaction was
 .stopped by adding 400 ml 4% wrv Triton X-114.
Control samples contained no Triton X-100 or no
PI-PLC. Hydrolysis of the GPI anchor of alkaline
phosphatase was assayed by measuring the distribu-
tion of alkaline phosphatase activity between aqueous
and detergent phase after phase partitioning in Triton
w xX-114 at 378C 31 .
2.9. SDSrPAGE and Western blotting
SDSrPAGE was performed under reducing condi-
w xtions according to Laemmli 34 using 5–15% poly-
acrylamide gradient gels. Proteins were blotted onto
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PVDF membranes and stained with anti-GPI-PLD
w xantibodies as described by Heller et al. 23 .
2.10. Immunofluorescence staining of transfected
COS-1 cells
Unless otherwise stated all procedures were per-
formed at room temperature. Sterile glass coverslips
were put into a 24-well culture tissue plate
 .FalconrBecton-Dickinson, Basel, Switzerland and
covered with 150 ml 0.1 mgrml poly-L-lysine solu-
tion. Following incubation for 1 h at 378C, the poly-
L-lysine solution was aspirated and the glass cover-
slips were washed twice with redistilled water and
 .once with DMEM containing 10% vrv FCS. About
3=104 exponentially growing cells were seeded onto
poly-L-lysine pre-coated glass coverslips and incu-
bated overnight at 378C. DEAE-dextran-mediated
transfection was carried out essentially as described
above except that 300 ml transfection cocktail con-
taining 0.3 mg DNA was used. The following day the
cells were washed thoroughly and incubated in
 . DMEM containing 1% vrv Nutridoma Boeh-
.ringer, Mannheim, Germany overnight at 378C.
Intracellular and cell surface staining of GPI-PLD
in transfected COS-1 cells was done using mouse
monoclonal anti-GPI-PLD antibody followed by in-
cubation with FITC-labelled rabbit anti-mouse anti-
w xbody as described by Grunberg et al. 35 .¨
2.11. Protein assay
Protein was determined using the BCA reagent kit
 .Pierce Chemicals, Rockford, IL, USA with bovine
serum albumin as standard.
3. Results
3.1. Expression of different forms of GPI-PLD in
COS-1 cells
The different GPI-PLD cDNAs used in this study
are shown in Fig. 1. All constructs were verified on
the cDNA level. Expression of the different forms of
GPI-PLD in COS-1 cells was analyzed using
SDSrPAGE followed by Western blotting using anti-
 .GPI-PLD antibody Fig. 2 . Our results showed that
COS-1 cells transfected with the different cDNA
constructs all expressed GPI-PLD protein Fig. 2,
.lanes b–d while mock transfected cells showed no
 .immunoreactive bands Fig. 2, lane e . The wild-type
and GPI-anchored forms of GPI-PLD in COS-1 cells
migrated as doublets of bands with apparent molecu-
 .lar masses of 95–100 kDa Fig. 2, lanes b,c and
were slightly smaller than purified GPI-PLD from
 .bovine serum 115 kDa; Fig. 2, lane a . These differ-
ences are likely the result of altered glycosylation of
GPI-PLD in COS-1 cells, since it has been shown
that the recombinant form of GPI-PLD and the serum
enzyme have an identical apparent molecular mass of
w x90 kDa after treatment with N-glycosidase F 36 .
Fig. 2. Expression of different forms of GPI-PLD. COS-1 cells
were transfected with wild-type, GPI-anchored and signal pep-
tide-deficient GPI-PLD cDNA and cells were collected 48 h
posttransfection. The transfected cells were analyzed on 5–15%
SDS-polyacrylamide gradient gels under reducing conditions,
blotted onto PVDF membranes, and stained with anti-GPI-PLD
antibody. For experimental details see Section 2. Lane a: purified
GPI-PLD from bovine serum; lane b: COS-1 cells expressing the
wild-type GPI-PLD; lane c: COS-1 cells expressing the GPI-
anchored GPI-PLD; lane d: COS-1 cells expressing the signal
peptide-deficient GPI-PLD; lane e: mock transfected COS-1 cells.
The gel was calibrated with the molecular mass standards myosin
 .  . 200 kDa , b-galactosidase 116 kDa , phosphorylase b 97.4
.  .  .kDa , bovine serum albumin 66 kDa , ovalbumin 45 kDa , and
 .carbonic anhydrase 31 kDa .
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The signal peptide-deficient form of GPI-PLD in
COS-1 cells migrated with an apparent molecular
 .mass of 90 kDa Fig. 2, lane d and represents a
non-glycosylated form of GPI-PLD.
The GPI-hydrolyzing activities of the different
forms of GPI-PLD expressed in COS-1 cells were
measured in the cell pellets and culture supernatants
using purified AChE as substrate. In COS-1 cells
transfected with the wild-type and GPI-anchored
forms of GPI-PLD, the majority of GPI-PLD activity
 .90% and 80%, respectively was secreted into the
culture supernatant with the remainder being associ-
ated with the cell pellet. In contrast, in COS-1 cells
transfected with the signal peptide-deficient form of
GPI-PLD, )95% of GPI anchor-hydrolyzing activ-
ity was associated with the cell pellet. The specific
activity of the signal peptide-deficient form of GPI-
PLD was 5–8 times lower than that of the wild-type
and 9–12 times lower than that of the GPI-anchored
enzyme, respectively range of three experiments; the
values from a typical experiment were: 104, 880 and
y1 y1 .1205 fmolPmin Pmg , respectively . Mock trans-
fected COS-1 cells showed no GPI-PLD enzymatic
activity in the cell pellet or the cell culture super-
natant. Similar results were obtained using GPI-
 .anchored VSG instead of AChE as substrate.
3.2. Immunofluorescence staining of GPI-PLD-trans-
fected COS-1 cells
In order to localize the different forms of GPI-PLD
in COS-1 cells, transfected cells were incubated with
anti-GPI-PLD antibody in the presence or absence of
detergent followed by incubation with FITC-labelled
second antibody. Our results using immunofluo-
rescence microscopy showed that cells expressing the
wild-type or signal peptide-deficient form of GPI-PLD
were labelled only after membrane permeabilization
 .with detergent Fig. 3, panels A, B, E, F . In contrast,
cells expressing the GPI-anchored form of GPI-PLD
were stained also in the absence of detergent Fig. 3,
.panels C, D reflecting a membrane-anchored form of
the enzyme. Mock transfected cells were not stained
 .under any condition data not shown .
[3 ]3.3. Labelling of COS-1 cells with H ethanolamine
The GPI core structure is linked to the C-terminal
amino acid of the protein via ethanolamine phos-
Fig. 3. Detection of the different forms of GPI-PLD in COS-1
cells by immunofluorescence staining. Permeabilized and non-
permeabilized transfected COS-1 cells were stained with mouse
monoclonal anti-GPI-PLD antibody followed by incubation with
FITC-conjugated rabbit anti-mouse antibody as described in Sec-
tion 2. Panels A and B: COS-1 cells transfected with wild-type
GPI-PLD cDNA; panels C and D: COS-1 cells transfected with
GPI-anchored GPI-PLD cDNA; panels E and F: COS-1 cells
transfected with signal peptide-deficient GPI-PLD cDNA; Mock
transfected COS-1 cells were not labelled under any condition
 .data not shown . Panels A, C, E: detergent-permeabilized cells;
panels B, D, F: non-permeabilized cells.
phate. It has been shown that incubation of cells with
w3 xH ethanolamine results in incorporation of radiola-
bel into GPI-anchored proteins reviewed by
w x.Vidugiriene and Menon 37 . In order to confirm that
the GPI-PLD cDNA containing the GPI attachment
signal resulted in posttranslational GPI modification
 .of GPI-PLD, we incubated transfected cells with
w3 xH ethanolamine 24 h posttransfection and analyzed
the labelled proteins by SDSrPAGE and autoradiog-
 .raphy Fig. 4 . Mock transfected COS-1 cells showed
a single radiolabelled band at approximately 45 kDa
 .Fig. 4, lane a . Although we have not pursued it
further, this protein is most likely to be translation
elongation factor EF-1a , which can be labelled with
w xethanolamine in a variety of cell types 38 . In con-
trast, in cells transfected with the cDNA encoding the
GPI-anchored form of GPI-PLD, an additional band
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w3 xFig. 4. H Ethanolamine labelling of COS-1 cells transfected
with GPI-anchored GPI-PLD. Mock transfected cells and cells
transfected with GPI-anchored GPI-PLD cDNA were incubated
24 h posttransfection in culture medium supplemented with 100
w3 xmCi H ethanolamine for 24 h. Cells and culture supernatants
were harvested, and equal amounts of protein were analyzed by
SDSrPAGE using 5–15% polyacrylamide gels followed by auto-
 .  .radiography. a cell pellet of mock transfected COS-1 cells; b
 .cell pellet and c culture supernatant of COS-1 cells transfected
with GPI-anchored GPI-PLD cDNA.
at approximately 100 kDa was labelled in both the
 .cell pellet Fig. 4, lane b and the culture supernatant
 .Fig. 4, lane c . This result demonstrates that the
expressed form of GPI-PLD in these cells is modified
by a GPI anchor.
3.4. Effects of GPI-PLD expression on endogenous
alkaline phosphatase in COS-1 cells
COS-1 cells contain endogenous alkaline phos-
w xphatase activity 33 . In order to study GPI anchoring
of alkaline phosphatase, non-transfected and mock
transfected COS-1 cells were treated with PI-PLC
followed by phase partitioning of the reaction prod-
ucts in Triton X-114. We found that the majority
 .70–90% of alkaline phosphatase activity was re-
leased from COS-1 cells by PI-PLC treatment indi-
cating that endogenous alkaline phosphatase is at-
tached to the cell membrane via GPI. In order to
study if the GPI anchor of endogenous alkaline phos-
phatase is a substrate for the expressed forms of
GPI-PLD, GPI-PLD-transfected COS-1 cells were
 .solubilized in 0.05% wrv Triton X-100 and incu-
bated for 16 h at 378C to allow GPI hydrolysis to
occur. We found that in the presence of detergent the
GPI anchor of endogenous alkaline phosphatase was
 .completely )90% hydrolyzed by all forms of GPI-
PLD, whereas no anchor hydrolysis was observed in
mock transfected cells.
Possible effects of GPI-PLD expression on en-
dogenous GPI-anchored protein in intact cells were
studied by analyzing endogenous alkaline phos-
phatase activity in GPI-PLD-transfected COS-1 cells.
We found that COS-1 cells expressing either the
wild-type or GPI-anchored form of GPI-PLD re-
leased endogenous alkaline phosphatase activity into
 .the cell culture supernatant Fig. 5, bars B, C . In
contrast, no increase in alkaline phosphatase activity
was observed in the culture supernatant of cells ex-
pressing the signal peptide-deficient form of GPI-PLD
as compared to mock transfected cells Fig. 5, bars D
.vs. A . These results were confirmed in two other
independent experiments.
Fig. 5. Endogenous alkaline phosphatase activity in cell culture
supernatants of cells transfected with the different GPI-PLD
cDNAs. Alkaline phosphatase activity was determined in cell
culture supernatants of COS-1 cells 72 h posttransfection. Bars:
A, mock transfected cells; B, cells transfected with the wild-type
GPI-PLD cDNA; C, cells transfected with the GPI-anchored
GPI-PLD cDNA; D, cells transfected with the signal peptide-de-
ficient GPI-PLD cDNA. The numbers represent mean values"
standard deviations of triplicate determinations from a typical
experiment.
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3.5. Effects of GPI-PLD expression on cotransfected
PLAP in COS-1 cells
It has been shown that transfection of PLAP into
COS-1 cells results in the expression of GPI-anchored
w xPLAP on the cell surface 20 . Similarly, we found
that after transfection of COS-1 cells with PLAP
 .cDNA the majority )90% of PLAP activity was
recovered in the cell pellet. Cell-associated PLAP
 .could be released completely )90% from the sur-
face of COS-1 cells by treatment with PI-PLC
demonstrating its membrane attachment via GPI.
In order to study possible effects of GPI-PLD
expression on membrane attachment of PLAP, we
cotransfected COS-1 cells with PLAP and the differ-
ent forms of GPI-PLD and analyzed the distribution
of PLAP activity between cell pellets and culture
supernatants. In COS-1 cells cotransfected with PLAP
and wild-type GPI-PLD, PLAP activity was dis-
tributed equally between cell pellet and culture super-
 .natant Fig. 6, panel B . This result is in agreement
w xwith an earlier report 20 . In contrast, in cells co-
transfected with PLAP and the GPI-anchored form of
GPI-PLD, more than 65% of PLAP activity was
 .recovered in the culture supernatant Fig. 6, panel C ,
whereas in COS-1 cells cotransfected with PLAP and
the signal peptide-deficient form of GPI-PLD, most
Fig. 6. Distribution of PLAP activity between cell pellets and
culture supernatants. COS-1 cells were cotransfected with PLAP
 .and the different GPI-PLD cDNAs. Cell pellets filled bars and
 .culture supernatants open bars were assayed for PLAP activity
in the presence of homoarginine to inhibit endogenous tissue-un-
specific alkaline phosphatase. COS-1 cells cotransfected with
. .PLAP and A the expression vector pSG5; B the wild-type
. .GPI-PLD cDNA; C the GPI-anchored GPI-PLD cDNA; and D
the signal peptide-deficient GPI-PLD cDNA. The numbers repre-
sent mean values"standard deviations of triplicate determina-
tions from three independent experiments.
of PLAP activity was recovered in the cell pellet
 .Fig. 6, panel D .
4. Discussion
Purified GPI-PLD is highly active towards deter-
gent-solubilized GPI-anchored proteins, but for rea-
sons that are not understood, is virtually inactive on
w xmembrane-bound substrates 14 . Furthermore, the
site of action of GPI-PLD has not been identified.
The enzyme is secreted by certain cell types in
w xculture 15,39 , and it has been shown that GPI-
anchored proteins were released from intact cells by a
w xcell-associated GPI-PLD in vivo 40 , indicating that
GPI anchor cleavage may occur intracellularly, i.e.
along the secretory pathway. Studies in which GPI-
anchored proteins and GPI-PLD have been cotrans-
fected into COS-1 cells support this hypothesis
w x20,25 . In order to further study the intracellular
action of GPI-PLD on membrane-bound substrates,
we designed two novel forms of the enzyme. By
deletion of the signal sequence on the GPI-PLD
cDNA, we generated a non-secretory form of GPI-
PLD that after transfection into COS-1 cells showed
a reduced specific enzymatic activity of approxi-
mately 15–20% as compared to the wild-type en-
zyme and was stably associated with the cell pellet.
The expressed protein had an apparent molecular
mass of 90 kDa reflecting a non-glycosylated form of
GPI-PLD. It could be visualized by immunofluo-
rescence only after detergent permeabilization of
COS-1 cells. These results are consistent with the
expression of a enzymatically active intracellular form
of GPI-PLD in COS-1 cells.
Alternatively, we generated a membrane-bound
form of GPI-PLD by addition of a GPI anchor attach-
ment signal to the full length GPI-PLD cDNA. We
found that transfection of this cDNA construct into
COS-1 cells resulted in the expression of an enzymat-
ically active protein with an apparent molecular mass
of 100 kDa. The cell-associated protein could be
w3 xlabelled with H ethanolamine and was localized on
the cell surface as demonstrated by immunofluo-
rescence microscopy indicating that it was mem-
brane-bound via GPI. However, the majority of GPI-
PLD activity in cells transfected with the GPI-
( )M. Kung et al.rBiochimica et Biophysica Acta 1357 1997 329–338¨ 337
anchored form of GPI-PLD was not membrane-bound
but instead found in the culture supernatant. Our
observation that GPI-PLD in the supernatant was also
w3 xlabelled with H ethanolamine indicates that the en-
zyme was released from the cells only after GPI
anchor attachment, most likely by cleavage of the
GPI structure by GPI-PLD. These results are consis-
tent with the expression of a GPI-anchored form of
GPI-PLD in COS-1 cells followed by GPI-PLD-
mediated hydrolysis of the GPI anchor and release of
the protein from the cell.
The effects of expression of the GPI-anchored and
signal peptide-deficient forms of GPI-PLD on GPI-
anchored proteins in COS-1 cells were studied by
analyzing the membrane attachment of endogenous
alkaline phosphatase and co-expressed PLAP. Ex-
pression of the GPI-anchored form of GPI-PLD re-
sulted in an increased release of endogenous alkaline
phosphatase activity from COS-1 cells. Concomi-
tantly, we observed a reduction in cell-associated
endogenous alkaline phosphatase activity. However,
 .the reduction was low 5–10% and within the range
of error for the alkaline phosphatase activity mea-
surements. This low level of reduction can be ex-
 .pected since only a small number of cells i.e. -10%
incorporate cDNA during a transient transfection pro-
cedure and thus, are expected to express GPI-PLD.
It has been shown previously that in COS-1 cells
 .co-expressing PLAP and the wild-type i.e. secretory
form of GPI-PLD, PLAP was secreted into the cul-
w xture supernatant 20 . In line with this report we
found that in cells cotransfected with wild-type GPI-
PLD, PLAP activity was distributed equally between
cell pellet and culture supernatant. Interestingly, the
relative amount of PLAP activity in the cell culture
supernatant increased considerably when COS-1 cells
were cotransfected with the GPI-anchored form of
GPI-PLD. This increased release of PLAP from cells
transfected with the GPI-anchored form of GPI-PLD
is unlikely the result of an increased transfection
efficiency since all transfection experiments were
done in an identical fashion using the same expres-
sion vector and the same number of COS-1 cells.
Rather, it may indicate that the attachment of a GPI
anchor to the GPI-PLD resulted in an increased
cleavage efficiency of the PLAP GPI anchor. Alterna-
tively, the increased release of PLAP may be due to
the slightly higher specific activity of the GPI-
anchored enzyme as compared to the wild-type GPI-
PLD.
In contrast, expression of the signal peptide-defi-
cient form of GPI-PLD in COS-1 cells had no effect
on GPI membrane attachment of endogenous alkaline
phosphatase or co-expressed PLAP. Since the initial
steps of GPI anchor biosynthesis occur at the cyto-
plasmic face of the endoplasmic reticulum reviewed
w x.by Vidugiriene and Menon 37 , this result indicates
that the intracellular form of GPI-PLD either had no
access to the GPI lipid precursors, or that the degree
of GPI precursor hydrolysis was not sufficient to
result in a reduced availability of GPI anchors for
protein modification. Alternatively, the low transfec-
tion efficiency together with the decreased specific
activity may have masked a possible reduction in the
levels of endogenous GPI-anchored alkaline phos-
phatase.
In summary, we transfected two novel GPI-PLD
cDNA constructs into COS-1 cells resulting in the
transient expression of catalytically active GPI-
anchored and intracellular forms of GPI-PLD. The
GPI-modified form of GPI-PLD effectively hydro-
lyzed both endogenous GPI-anchored alkaline phos-
phatase as well as cotransfected PLAP while the
intracellular form of GPI-PLD showed no effect on
GPI protein attachment. Similar results were obtained
in preliminary experiments using COS-1 cells that
were stably transformed with the different GPI-PLD
cDNAs M. Kung and B. Stadelmann, unpublished¨
.data . It will be interesting to study how the stable
expression of the two novel forms of GPI-PLD will
 .affect GPI lipid biosynthesis in COS-1 cells.
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